A, a 35-year-old nonbinary patient with a complex psychiatric history, including major depressive disorder with psychotic features, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD), who developed tardive dyskinesia (TD) following stimulant (amphetamine/dextroamphetamine) initiation, which improved significantly after discontinuing the stimulant and switching to quetiapine. The case highlights the challenges of managing TD in patients with overlapping…
